| Dr Jeffrey P Callen, MD | |
|
3810 Springhurst Blvd, Suite 200, Louisville, KY 40241-6100 | |
| (502) 583-1749 | |
| (502) 329-8184 |
| Full Name | Dr Jeffrey P Callen |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 52 Years |
| Location | 3810 Springhurst Blvd, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508872821 | NPI | - | NPPES |
| 64189111 | Medicaid | KY | |
| 100347190 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 18911 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Dermatology, Pllc | 1658263876 | 32 |
News Archive
Author Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in this Foreign Policy opinion piece that the announcement researchers from the Netherlands and the U.S. have developed a supercontagious variety of bird flu "has highlighted a dilemma: How do you balance the universal mandate for scientific openness against the fear that terrorists or rogue states might follow the researchers' work - using it as catastrophic cookbooks for global influenza contagion?"
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
A study that looked at mainstreaming genetic counseling for ovarian cancer to support screening programs in Malaysia was presented at the ESMO Asia 2017 Congress.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
› Verified 7 days ago
| Entity Name | Associates In Dermatology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629083399 PECOS PAC ID: 1658263876 Enrollment ID: O20040325000047 |
News Archive
Author Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in this Foreign Policy opinion piece that the announcement researchers from the Netherlands and the U.S. have developed a supercontagious variety of bird flu "has highlighted a dilemma: How do you balance the universal mandate for scientific openness against the fear that terrorists or rogue states might follow the researchers' work - using it as catastrophic cookbooks for global influenza contagion?"
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
A study that looked at mainstreaming genetic counseling for ovarian cancer to support screening programs in Malaysia was presented at the ESMO Asia 2017 Congress.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey P Callen, MD Po Box 950132, Louisville, KY 40295-0132 Ph: (888) 980-8992 | Dr Jeffrey P Callen, MD 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241-6100 Ph: (502) 583-1749 |
News Archive
Author Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in this Foreign Policy opinion piece that the announcement researchers from the Netherlands and the U.S. have developed a supercontagious variety of bird flu "has highlighted a dilemma: How do you balance the universal mandate for scientific openness against the fear that terrorists or rogue states might follow the researchers' work - using it as catastrophic cookbooks for global influenza contagion?"
Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.
A study that looked at mainstreaming genetic counseling for ovarian cancer to support screening programs in Malaysia was presented at the ESMO Asia 2017 Congress.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
› Verified 7 days ago
Mrs. Jyoti B. Burruss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-583-1749 Fax: 502-329-8184 | |
Dr. Jae Yeon Jung, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd Ste 200, Louisville, KY 40241 Phone: 502-583-1749 Fax: 502-329-8184 | |
Vilma C Fabre, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2211 Greene Way, Ste 100, Louisville, KY 40220 Phone: 502-495-1162 Fax: 502-495-0156 | |
Elizabeth Veasey, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 | |
Andrea S Burch, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2307 Greene Way Ste C, Louisville, KY 40220 Phone: 502-806-3376 Fax: 502-213-3999 | |
Dr. Steven J Hodge, MD Dermatology Medicare: Medicare Enrolled Practice Location: 310 E Broadway, Ste 200, Louisville, KY 40202 Phone: 502-585-5249 Fax: 502-585-5251 | |
Dr. Michael Mccall Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 200, Louisville, KY 40241 Phone: 502-322-1946 Fax: 502-329-8184 |